Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Kala Pharmaceuticals to sell Eysuvis, Inveltys assets to Alcon for $60M upfront » 05:30
05/23/22
05/23
05:30
05/23/22
05:30
KALA

Kala Pharmaceuticals

/

+

, ALC

Alcon

$72.65 /

+0.42 (+0.58%)

Kala Pharmaceuticals…

Kala Pharmaceuticals (KALA) announced that it has entered into a definitive agreement to sell its commercial portfolio and related intellectual property assets to Alcon (ALC). This includes Eysuvis, the first and only FDA approved medicine for the short-term treatment of the signs and symptoms of dry eye disease, and Inveltys, a twice-a-day corticosteroid for the treatment of post-operative inflammation and pain following ocular surgery. Kala plans to focus on developing KPI-012, a novel cell-free secretome therapy that has the potential to address a number of rare and severe ocular diseases. Subject to the submission and clearance of an investigational new drug application for KPI-012, Kala expects to initiate a Phase 2/3 clinical trial of KPI-012 for persistent corneal epithelial defect, or PCED, in the fourth quarter of 2022 and plans to expand its development program for KPI-012 into additional front and back of the eye indications, with additional details forthcoming in the months ahead. Following the closing of the sale of its commercial assets, Kala expects to realize a substantial reduction in operating expenses, which together with the net proceeds from the upfront cash payment received from this transaction, will extend Kala's operating cash runway into the second quarter of 2024, beyond the expected KPI-012 Phase 2/3 data readout. Under the terms of the asset purchase agreement, Kala will receive an upfront payment of $60M and will be eligible to receive commercial-based sales milestone payments. Kala anticipates the transaction will close in the third quarter of 2022, subject to certain conditions, including the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions.

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
/

+

ALC Alcon
$72.65 /

+0.42 (+0.58%)

KALA Kala Pharmaceuticals
/

+

05/17/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $5 from $6 at H.C. Wainwright
03/30/22 Northland
Kala Pharmaceuticals price target lowered to $4 from $6 at Northland
03/30/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $6 from $9 at H.C. Wainwright
03/30/22 JPMorgan
Kala Pharmaceuticals downgraded to Underweight from Neutral at JPMorgan
ALC Alcon
$72.65 /

+0.42 (+0.58%)

05/12/22 Credit Suisse
Alcon assumed with an Outperform at Credit Suisse
05/12/22 JPMorgan
Alcon price target lowered to CHF 68.80 from CHF 69 at JPMorgan
05/12/22 Stephens
Alcon upgraded to Overweight at Stephens following Q1 report
05/12/22 Stephens
Alcon upgraded to Overweight from Equal Weight at Stephens
KALA Kala Pharmaceuticals
/

+

ALC Alcon
$72.65 /

+0.42 (+0.58%)

ALC Alcon
$72.65 /

+0.42 (+0.58%)

KALA Kala Pharmaceuticals
/

+

Conference/Events
Alcon management to meet virtually with BTIG » 04:55
05/20/22
05/20
04:55
05/20/22
04:55
ALC

Alcon

$72.23 /

+1.67 (+2.37%)

Medical Technology…

Medical Technology Analyst Zimmerman holds a virtual meeting with management on May 20 hosted by BTIG.

ShowHide Related Items >><<
ALC Alcon
$72.23 /

+1.67 (+2.37%)

ALC Alcon
$72.23 /

+1.67 (+2.37%)

05/12/22 Credit Suisse
Alcon assumed with an Outperform at Credit Suisse
05/12/22 JPMorgan
Alcon price target lowered to CHF 68.80 from CHF 69 at JPMorgan
05/12/22 Stephens
Alcon upgraded to Overweight at Stephens following Q1 report
05/12/22 Stephens
Alcon upgraded to Overweight from Equal Weight at Stephens
ALC Alcon
$72.23 /

+1.67 (+2.37%)

ALC Alcon
$72.23 /

+1.67 (+2.37%)

Initiation
Alcon assumed with an Outperform at Credit Suisse » 16:43
05/12/22
05/12
16:43
05/12/22
16:43
ALC

Alcon

$68.87 /

-0.94 (-1.35%)

Credit Suisse analyst…

Credit Suisse analyst Christoph Gretler assumed coverage of Alcon with an Outperform rating and $96 price target.

ShowHide Related Items >><<
ALC Alcon
$68.87 /

-0.94 (-1.35%)

ALC Alcon
$68.87 /

-0.94 (-1.35%)

05/12/22 JPMorgan
Alcon price target lowered to CHF 68.80 from CHF 69 at JPMorgan
05/12/22 Stephens
Alcon upgraded to Overweight at Stephens following Q1 report
05/12/22 Stephens
Alcon upgraded to Overweight from Equal Weight at Stephens
04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
ALC Alcon
$68.87 /

-0.94 (-1.35%)

ALC Alcon
$68.87 /

-0.94 (-1.35%)

Recommendations
Alcon price target lowered to CHF 68.80 from CHF 69 at JPMorgan » 15:07
05/12/22
05/12
15:07
05/12/22
15:07
ALC

Alcon

$68.20 /

-1.61 (-2.31%)

JPMorgan analyst James…

JPMorgan analyst James Gordon lowered the firm's price target on Alcon to CHF 68.80 from CHF 69 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
ALC Alcon
$68.20 /

-1.61 (-2.31%)

ALC Alcon
$68.20 /

-1.61 (-2.31%)

05/12/22 Stephens
Alcon upgraded to Overweight at Stephens following Q1 report
05/12/22 Stephens
Alcon upgraded to Overweight from Equal Weight at Stephens
04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
04/08/22 Needham
Alcon initiated with a Buy at Needham
ALC Alcon
$68.20 /

-1.61 (-2.31%)

ALC Alcon
$68.20 /

-1.61 (-2.31%)

Conference/Events
Alcon management to meet virtually with BTIG » 12:59
05/12/22
05/12
12:59
05/12/22
12:59
ALC

Alcon

$68.63 /

-1.18 (-1.69%)

Medical Technology…

Medical Technology Analyst Zimmerman holds a virtual meeting with management on May 20 hosted by BTIG.

ShowHide Related Items >><<
ALC Alcon
$68.63 /

-1.18 (-1.69%)

ALC Alcon
$68.63 /

-1.18 (-1.69%)

05/12/22 Stephens
Alcon upgraded to Overweight at Stephens following Q1 report
05/12/22 Stephens
Alcon upgraded to Overweight from Equal Weight at Stephens
04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
04/08/22 Needham
Alcon initiated with a Buy at Needham
ALC Alcon
$68.63 /

-1.18 (-1.69%)

ALC Alcon
$68.63 /

-1.18 (-1.69%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:07
05/12/22
05/12
10:07
05/12/22
10:07
WBD

Warner Bros. Discovery

$16.91 /

+0.29 (+1.74%)

, EVGO

EVgo

$7.27 /

+0.105 (+1.47%)

, IGT

International Game

$19.41 /

-0.37 (-1.87%)

, SCPL

SciPlay

$12.91 /

+0.825 (+6.83%)

, ALC

Alcon

$69.04 /

-0.77 (-1.10%)

, ZM

Zoom Video

$82.57 /

-2.22 (-2.62%)

, COUP

Coupa Software

$61.25 /

-3.24 (-5.02%)

, AXP

American Express

$154.27 /

-4.94 (-3.10%)

, COF

Capital One

$116.16 /

-3.29 (-2.75%)

, DFS

Discover

$100.77 /

-3.92 (-3.74%)

, SYF

Synchrony

$33.76 /

-1.57 (-4.44%)

, BYND

Beyond Meat

$25.08 /

-1.055 (-4.04%)

, AVYA

Avaya

$5.73 /

-0.09 (-1.55%)

, BYD

Boyd Gaming

$53.29 /

-0.04 (-0.08%)

, DOCN

DigitalOcean

$31.20 /

+0.34 (+1.10%)

, STRY

Starry

$6.38 /

-1.24 (-16.27%)

, TMCI

Treace Medical

$13.10 /

+0.17 (+1.31%)

, ISEE

Iveric bio

$9.66 /

-0.485 (-4.78%)

Institutional investors…

ShowHide Related Items >><<
ZM Zoom Video
$82.57 /

-2.22 (-2.62%)

WBD Warner Bros. Discovery
$16.91 /

+0.29 (+1.74%)

TMCI Treace Medical
$13.10 /

+0.17 (+1.31%)

SYF Synchrony
$33.76 /

-1.57 (-4.44%)

STRY Starry
$6.38 /

-1.24 (-16.27%)

SCPL SciPlay
$12.91 /

+0.825 (+6.83%)

ISEE Iveric bio
$9.66 /

-0.485 (-4.78%)

IGT International Game
$19.41 /

-0.37 (-1.87%)

EVGO EVgo
$7.27 /

+0.105 (+1.47%)

DOCN DigitalOcean
$31.20 /

+0.34 (+1.10%)

DFS Discover
$100.77 /

-3.92 (-3.74%)

COUP Coupa Software
$61.25 /

-3.24 (-5.02%)

COF Capital One
$116.16 /

-3.29 (-2.75%)

BYND Beyond Meat
$25.08 /

-1.055 (-4.04%)

BYD Boyd Gaming
$53.29 /

-0.04 (-0.08%)

AXP American Express
$154.27 /

-4.94 (-3.10%)

AVYA Avaya
$5.73 /

-0.09 (-1.55%)

ALC Alcon
$69.04 /

-0.77 (-1.10%)

WBD Warner Bros. Discovery
$16.91 /

+0.29 (+1.74%)

05/12/22 Cowen
Warner Bros. Discovery upgraded on management strategy at Cowen
05/12/22 Cowen
Warner Bros. Discovery upgraded to Outperform from Market Perform at Cowen
04/27/22 Barclays
Warner Bros. Discovery initiated with an Equal Weight at Barclays
04/25/22 Morgan Stanley
Morgan Stanley reiterates Equal Weight on Warner Bros. Discovery after closing
EVGO EVgo
$7.27 /

+0.105 (+1.47%)

05/12/22 Credit Suisse
Credit Suisse upgrades EVgo to Outperform with $14 price target
05/12/22 Credit Suisse
EVgo upgraded to Outperform from Neutral at Credit Suisse
04/28/22 Cantor Fitzgerald
EVgo initiated with an Overweight at Cantor Fitzgerald
04/28/22 Cantor Fitzgerald
EVgo initiated with an Overweight at Cantor Fitzgerald
IGT International Game
$19.41 /

-0.37 (-1.87%)

05/12/22 Jefferies
International Game upgraded to Buy at Jefferies on inherent stability
05/12/22 Jefferies
International Game upgraded to Buy from Hold at Jefferies
05/11/22 Deutsche Bank
International Game price target lowered to $37 from $39 at Deutsche Bank
03/08/22 Susquehanna
International Game price target raised to $24 from $11 at Susquehanna
SCPL SciPlay
$12.91 /

+0.825 (+6.83%)

05/12/22 Truist
SciPlay upgraded to Buy from Hold at Truist
05/12/22 Truist
SciPlay upgraded to Buy from Hold at Truist
04/19/22 Goldman Sachs
SciPlay assumed with a Buy at Goldman Sachs
03/03/22 DA Davidson
SciPlay upgraded to Buy at DA Davidson on ramping fundamentals
ALC Alcon
$69.04 /

-0.77 (-1.10%)

05/12/22 Stephens
Alcon upgraded to Overweight at Stephens following Q1 report
05/12/22 Stephens
Alcon upgraded to Overweight from Equal Weight at Stephens
04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
04/08/22 Needham
Alcon initiated with a Buy at Needham
ZM Zoom Video
$82.57 /

-2.22 (-2.62%)

05/12/22 Piper Sandler
Zoom Video downgraded to Neutral from Overweight at Piper Sandler
03/29/22 Exane BNP Paribas
Zoom Video initiated with a Neutral at Exane BNP Paribas
03/15/22 Wells Fargo
Zoom Video price target lowered to $105 from $145 at Wells Fargo
03/15/22 Benchmark
Zoom Video upgraded to Buy from Hold at Benchmark
COUP Coupa Software
$61.25 /

-3.24 (-5.02%)

05/12/22 Goldman Sachs
Coupa Software downgraded to Sell from Buy at Goldman Sachs
04/08/22 BMO Capital
Coupa Software price target raised to $110 from $82 at BMO Capital
04/06/22 Evercore ISI
Coupa Software upgraded to Outperform from In Line at Evercore ISI
03/16/22 UBS
Coupa Software price target lowered to $105 from $130 at UBS
AXP American Express
$154.27 /

-4.94 (-3.10%)

05/12/22 Wolfe Research
Wolfe downgrades credit card issuers on 80% probability of recession
05/12/22 Wolfe Research
American Express downgraded to Peer Perform from Outperform at Wolfe Research
04/26/22 Citi
American Express price target raised to $190 from $187 at Citi
04/25/22 RBC Capital
American Express price target raised to $200 from $195 at RBC Capital
COF Capital One
$116.16 /

-3.29 (-2.75%)

05/12/22 Wolfe Research
Capital One downgraded to Underperform from Peer Perform at Wolfe Research
04/27/22 Oppenheimer
Capital One price target lowered to $157 from $163 at Oppenheimer
04/27/22 BMO Capital
Capital One price target lowered to $188 from $200 at BMO Capital
DFS Discover
$100.77 /

-3.92 (-3.74%)

05/12/22 Wolfe Research
Discover downgraded to Peer Perform from Outperform at Wolfe Research
04/29/22 Deutsche Bank
Discover price target raised to $150 from $145 at Deutsche Bank
04/29/22 Citi
Discover price target raised to $157 from $154 at Citi
SYF Synchrony
$33.76 /

-1.57 (-4.44%)

05/12/22 Wolfe Research
Synchrony downgraded to Underperform from Peer Perform at Wolfe Research
04/19/22 BMO Capital
Synchrony price target raised to $52 from $49 at BMO Capital
04/06/22 Wells Fargo
Synchrony price target lowered to $45 from $52 at Wells Fargo
BYND Beyond Meat
$25.08 /

-1.055 (-4.04%)

05/12/22 BMO Capital
Beyond Meat price target lowered to $30 from $60 at BMO Capital
05/12/22 Cowen
Beyond Meat price target lowered to $26 from $42 at Cowen
05/12/22 Mizuho
Beyond Meat price target lowered to $21 from $35 at Mizuho
05/12/22 Piper Sandler
Beyond Meat price target lowered to $12 from $29 at Piper Sandler
AVYA Avaya
$5.73 /

-0.09 (-1.55%)

05/12/22 BWS Financial
Avaya downgraded to Sell from Buy at BWS Financial
05/11/22 Craig-Hallum
Avaya price target lowered to $13 from $30 at Craig-Hallum
05/11/22 Barclays
Avaya price target lowered to $8 from $11 at Barclays
05/11/22 JPMorgan
JPMorgan downgrades Avaya to Underweight on elongated transformation
BYD Boyd Gaming
$53.29 /

-0.04 (-0.08%)

05/12/22 Berenberg
Berenberg starts Boyd Gaming at Buy amid Vegas local 'duopoly'
05/12/22 Berenberg
Boyd Gaming initiated with a Buy at Berenberg
04/27/22 Susquehanna
Boyd Gaming price target raised to $79 from $74 at Susquehanna
04/26/22 Susquehanna
Boyd Gaming upgraded to Positive from Neutral at Susquehanna
DOCN DigitalOcean
$31.20 /

+0.34 (+1.10%)

05/12/22 Goldman Sachs
DigitalOcean initiated with a Buy at Goldman Sachs
05/05/22 JMP Securities
DigitalOcean price target lowered to $63 from $94 at JMP Securities
05/05/22 Oppenheimer
DigitalOcean price target lowered to $80 from $96 at Oppenheimer
05/05/22 Barclays
DigitalOcean price target lowered to $55 from $70 at Barclays
STRY Starry
$6.38 /

-1.24 (-16.27%)

05/12/22 Citi
Starry initiated with a Neutral at Citi
04/25/22 Goldman Sachs
Starry initiated with a Buy at Goldman Sachs
TMCI Treace Medical
$13.10 /

+0.17 (+1.31%)

05/12/22 BTIG
Treace Medical initiated with a Buy at BTIG
03/15/22 JPMorgan
Treace Medical trades at attractive entry point, says JPMorgan
01/07/22 Morgan Stanley
Treace Medical upgraded to Overweight at Morgan Stanley after pullback
01/07/22 Morgan Stanley
Treace Medical upgraded to Overweight from Equal Weight at Morgan Stanley
ISEE Iveric bio
$9.66 /

-0.485 (-4.78%)

05/12/22 B. Riley
B. Riley puts Neutral rating on Iveric bio in 'contrarian call'
05/12/22 B. Riley
Iveric bio initiated with a Neutral at B. Riley
05/04/22 Stifel
Iveric bio price target raised to $28 from $22 at Stifel
03/22/22 Jefferies
Jefferies starts Iveric bio at Buy, sees clear approval path for Zimura
ZM Zoom Video
$82.57 /

-2.22 (-2.62%)

WBD Warner Bros. Discovery
$16.91 /

+0.29 (+1.74%)

TMCI Treace Medical
$13.10 /

+0.17 (+1.31%)

SYF Synchrony
$33.76 /

-1.57 (-4.44%)

STRY Starry
$6.38 /

-1.24 (-16.27%)

SCPL SciPlay
$12.91 /

+0.825 (+6.83%)

ISEE Iveric bio
$9.66 /

-0.485 (-4.78%)

IGT International Game
$19.41 /

-0.37 (-1.87%)

EVGO EVgo
$7.27 /

+0.105 (+1.47%)

DOCN DigitalOcean
$31.20 /

+0.34 (+1.10%)

DFS Discover
$100.77 /

-3.92 (-3.74%)

COUP Coupa Software
$61.25 /

-3.24 (-5.02%)

COF Capital One
$116.16 /

-3.29 (-2.75%)

BYND Beyond Meat
$25.08 /

-1.055 (-4.04%)

BYD Boyd Gaming
$53.29 /

-0.04 (-0.08%)

AXP American Express
$154.27 /

-4.94 (-3.10%)

AVYA Avaya
$5.73 /

-0.09 (-1.55%)

ALC Alcon
$69.04 /

-0.77 (-1.10%)

  • 22
    Oct
  • 13
    Jul
  • 28
    May
ZM Zoom Video
$82.57 /

-2.22 (-2.62%)

WBD Warner Bros. Discovery
$16.91 /

+0.29 (+1.74%)

STRY Starry
$6.38 /

-1.24 (-16.27%)

DFS Discover
$100.77 /

-3.92 (-3.74%)

COF Capital One
$116.16 /

-3.29 (-2.75%)

BYND Beyond Meat
$25.08 /

-1.055 (-4.04%)

BYD Boyd Gaming
$53.29 /

-0.04 (-0.08%)

AXP American Express
$154.27 /

-4.94 (-3.10%)

ZM Zoom Video
$82.57 /

-2.22 (-2.62%)

WBD Warner Bros. Discovery
$16.91 /

+0.29 (+1.74%)

SYF Synchrony
$33.76 /

-1.57 (-4.44%)

SCPL SciPlay
$12.91 /

+0.825 (+6.83%)

ISEE Iveric bio
$9.66 /

-0.485 (-4.78%)

EVGO EVgo
$7.27 /

+0.105 (+1.47%)

DOCN DigitalOcean
$31.20 /

+0.34 (+1.10%)

DFS Discover
$100.77 /

-3.92 (-3.74%)

COUP Coupa Software
$61.25 /

-3.24 (-5.02%)

COF Capital One
$116.16 /

-3.29 (-2.75%)

BYND Beyond Meat
$25.08 /

-1.055 (-4.04%)

BYD Boyd Gaming
$53.29 /

-0.04 (-0.08%)

AXP American Express
$154.27 /

-4.94 (-3.10%)

AVYA Avaya
$5.73 /

-0.09 (-1.55%)

ALC Alcon
$69.04 /

-0.77 (-1.10%)

ZM Zoom Video
$82.57 /

-2.22 (-2.62%)

WBD Warner Bros. Discovery
$16.91 /

+0.29 (+1.74%)

SYF Synchrony
$33.76 /

-1.57 (-4.44%)

STRY Starry
$6.38 /

-1.24 (-16.27%)

IGT International Game
$19.41 /

-0.37 (-1.87%)

EVGO EVgo
$7.27 /

+0.105 (+1.47%)

DOCN DigitalOcean
$31.20 /

+0.34 (+1.10%)

DFS Discover
$100.77 /

-3.92 (-3.74%)

COUP Coupa Software
$61.25 /

-3.24 (-5.02%)

COF Capital One
$116.16 /

-3.29 (-2.75%)

BYND Beyond Meat
$25.08 /

-1.055 (-4.04%)

AXP American Express
$154.27 /

-4.94 (-3.10%)

AVYA Avaya
$5.73 /

-0.09 (-1.55%)

Upgrade
Alcon upgraded to Overweight at Stephens following Q1 report » 06:55
05/12/22
05/12
06:55
05/12/22
06:55
ALC

Alcon

$69.81 /

+4.555 (+6.98%)

Stephens analyst Chris…

Stephens analyst Chris Cooley upgraded Alcon to Overweight from Equal Weight with a price target of $92, up from $86, following the company's Q1 report and reaffirming of its 2022 guidance. Revenue and core earnings exceeded consensus by 6.3% and 28.3%, respectively, noted Cooley, who said the core business is executing well, with growth being led by new product cycles. He also notes that Alcon's "defensive and primarily non-discretionary" end markets are returning to pre-COVID norms while the stock's valuation is at a relative discount to comparable large cap med tech industry peers.

ShowHide Related Items >><<
ALC Alcon
$69.81 /

+4.555 (+6.98%)

ALC Alcon
$69.81 /

+4.555 (+6.98%)

05/12/22 Stephens
Alcon upgraded to Overweight from Equal Weight at Stephens
04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
04/08/22 Needham
Alcon initiated with a Buy at Needham
03/11/22 BofA
Alcon initiated with a Buy at BofA
ALC Alcon
$69.81 /

+4.555 (+6.98%)

ALC Alcon
$69.81 /

+4.555 (+6.98%)

Upgrade
Alcon upgraded to Overweight from Equal Weight at Stephens » 06:46
05/12/22
05/12
06:46
05/12/22
06:46
ALC

Alcon

$69.81 /

+4.555 (+6.98%)

Stephens analyst Chris…

Stephens analyst Chris Cooley upgraded Alcon to Overweight from Equal Weight with a $92 price target.

ShowHide Related Items >><<
ALC Alcon
$69.81 /

+4.555 (+6.98%)

ALC Alcon
$69.81 /

+4.555 (+6.98%)

04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
04/08/22 Needham
Alcon initiated with a Buy at Needham
03/11/22 BofA
Alcon initiated with a Buy at BofA
02/17/22 JPMorgan
Alcon price target lowered to CHF 69 from CHF 72.20 at JPMorgan
ALC Alcon
$69.81 /

+4.555 (+6.98%)

ALC Alcon
$69.81 /

+4.555 (+6.98%)

Earnings
Alcon reports Q1 EPS 68c vs. 49c y/y » 16:54
05/10/22
05/10
16:54
05/10/22
16:54
ALC

Alcon

$65.35 /

+1.07 (+1.66%)

Reports Q1 revenue $2.18B…

Reports Q1 revenue $2.18B vs. $1.91B y/y. "We saw a strong start to the year and our first quarter results demonstrate the continued strength of our innovative product portfolio and commercial execution," said David J. Endicott, CEO. "The Alcon team delivered double-digit sales growth in both our franchises, which drove operating leverage and improved profitability across the business. While we are pleased with these results, we continue to expect broader headwinds, including inflation and foreign exchange pressures, to persist. Despite this, we are increasing our constant currency growth outlook for 2022 based on our strong underlying business and growing market shares. I want to thank our 24,000 associates for their continued commitment and dedication to helping people see brilliantly."

ShowHide Related Items >><<
ALC Alcon
$65.35 /

+1.07 (+1.66%)

ALC Alcon
$65.35 /

+1.07 (+1.66%)

04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
04/08/22 Needham
Alcon initiated with a Buy at Needham
03/11/22 BofA
Alcon initiated with a Buy at BofA
02/17/22 JPMorgan
Alcon price target lowered to CHF 69 from CHF 72.20 at JPMorgan
ALC Alcon
$65.35 /

+1.07 (+1.66%)

ALC Alcon
$65.35 /

+1.07 (+1.66%)

Earnings
Alcon backs FY22 EPS view of $2.35-$2.45, consensus $2.41 » 16:54
05/10/22
05/10
16:54
05/10/22
16:54
ALC

Alcon

$65.35 /

+1.07 (+1.66%)

Backs FY22 revenue view…

Backs FY22 revenue view of $8.7B-$8.9B, consensus $8.63B

ShowHide Related Items >><<
ALC Alcon
$65.35 /

+1.07 (+1.66%)

ALC Alcon
$65.35 /

+1.07 (+1.66%)

04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
04/08/22 Needham
Alcon initiated with a Buy at Needham
03/11/22 BofA
Alcon initiated with a Buy at BofA
02/17/22 JPMorgan
Alcon price target lowered to CHF 69 from CHF 72.20 at JPMorgan
ALC Alcon
$65.35 /

+1.07 (+1.66%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.